SlideShare une entreprise Scribd logo
1  sur  2
Télécharger pour lire hors ligne
Page 1 of 2
COLIN MANSFIELD
Address: Lyon, France
Citizenship: British
PROFESSIONAL HISTORY
Principal Medical Writer and IP Manager at AB Science, Paris, France. (June 2008 - present)
Marie Curie Research Fellow at Institut des Nanotechnologies, ECL, Lyon, France. (Nov 2006 – June 2008)
Research Associate at NRC, Institute for Biodiagnostics, Winnipeg, Canada. (2001 - 2006)
PROFESSIONAL SKILLS AND EXPERIENCE
Principal Medical Writer for a fully integrated pharmaceutical company that develops targeted therapies in the
fields of oncology, immune-mediated diseases and neurological disorders. This entails the drafting, review and
editing of clinical study documentation, regulatory submission documentation, and medical communications. More
specifically:
 Articles for peer-review journals; submission planning; conference abstracts, slide-sets and posters; scientific
promotional, webpage and educational materials; press releases.
 Marketing authorization (eCTD module 2) and orphan drug designation applications, response to health
authorities and affiliate questions, regulatory annual reports (FDA and EMA), clinical study reports according
to ICH, Investigator Brochure, scientific rationale, study protocols, informed consent forms, SOPs.
 Participant at meetings for EMA centralized marketing authorization application; pre-submission through to
Scientific Advisory Group appeal hearings.
 Responsible for recruitment of new medical writers and regulatory affairs staff.
Intellectual Property Manager primarily entailing drafting and prosecution of pharmaceutical method-of-use
patents, intellectual property strategic planning, management of current patents and patent applications,
identification of inventions and filing of new patents.
Scientific Editor of a book published by Springer Press as part of their Methods in Molecular Biology Series on
the topic of microfluidic diagnostics.
Lead Scientist on several projects, including clinical and preclinical studies requiring the collection, analysis and
reporting of data in the fields of nanobiotechnology and biomedical infrared spectroscopy.
Adaptability, self-reliance and teamwork are evident in the breadth of medical/scientific communication tasks
undertaken and the variety of senior and junior staff collaborations.
Page 2 of 2
ACADEMIC BACKGROUND
Optical Research Centre
University of Southampton, UK
Ph.D. in Biomedical Physics (1994 - 2000)
Biomedical Physics Group
University of Exeter, UK
M.Sc. Medical Physics (1993 - 1994)
Royal Holloway University of
London, UK
B.Sc. Physics with Astrophysics
2:1 (Hons)
(1990 - 1993)
ACHIEVEMENTS AND FELLOWSHIPS
Authored over 25 articles in peer-reviewed journals including eight as first author and three book chapters.
Medical writing contributions and critical review acknowledged in many others articles.
Book editor: Microfluidic Diagnostics - Methods and Protocols. Series: Methods in Molecular Biology,
Volume 949, 2013. Over 100K chapters downloaded to date. Personal project.
PCT international patent 10 May 2005 (IPSO 1589-1): CD Mansfield and RA Shaw, National Research
Council Canada, “Microfluidic Preconditioning of (Bio)Fluids for Reagent free Infrared Clinical Analysis and
Diagnostics”.
Research funding from the Marie Curie Intra-European Fellowship, “Lab-on-a-chip based analyzers for point-
of-care monitoring of cancer therapy”, 2006: awarded € 161,000.
Research funding from the Manitoba Medical Service Foundation, “Point-of-care measurements for chronic
kidney disease based upon infrared spectroscopy”, 2005: awarded $ 22,000 CDN.
Ph.D. studentship from the Southampton University, UK, 1994: awarded course fees and living allowance.
Studentship from Engineering and the Physical Sciences Research Council, “Medical physics MSc
programme” at Exeter University, UK, 1993: awarded course fees and living allowance.

Contenu connexe

Tendances

Chemsem news fall 2013 flyer 3
Chemsem news fall 2013 flyer 3Chemsem news fall 2013 flyer 3
Chemsem news fall 2013 flyer 3Tom Loughran
 
cvofdrayubqureshi-RESEARCH 2
cvofdrayubqureshi-RESEARCH 2cvofdrayubqureshi-RESEARCH 2
cvofdrayubqureshi-RESEARCH 2Ayub Qureshi
 
Foresight in medicine: research induced society changes in the next decade
Foresight in medicine: research induced society changes in the next decadeForesight in medicine: research induced society changes in the next decade
Foresight in medicine: research induced society changes in the next decadeCaroline McClain
 
ciclo autonomico-short paper - Witfor 2016 paper_42
ciclo autonomico-short paper - Witfor 2016 paper_42ciclo autonomico-short paper - Witfor 2016 paper_42
ciclo autonomico-short paper - Witfor 2016 paper_42.. ..
 
AUTOMATED SYSTEM FOR PLANT DISEASE DIAGNOSIS BY USING IMAGE PROCESSING
AUTOMATED SYSTEM FOR PLANT DISEASE DIAGNOSIS BY USING IMAGE PROCESSINGAUTOMATED SYSTEM FOR PLANT DISEASE DIAGNOSIS BY USING IMAGE PROCESSING
AUTOMATED SYSTEM FOR PLANT DISEASE DIAGNOSIS BY USING IMAGE PROCESSINGVigneshVikki10
 
190228 pitch student group 3 microresonator platform to detect cancer (smb me...
190228 pitch student group 3 microresonator platform to detect cancer (smb me...190228 pitch student group 3 microresonator platform to detect cancer (smb me...
190228 pitch student group 3 microresonator platform to detect cancer (smb me...SMBBV
 
Mass spectroscopy
Mass spectroscopyMass spectroscopy
Mass spectroscopyVINOTH R
 
INBIOMEDvision IV Symposium Biomedical Informatics in Europe
INBIOMEDvision  IV Symposium Biomedical Informatics in EuropeINBIOMEDvision  IV Symposium Biomedical Informatics in Europe
INBIOMEDvision IV Symposium Biomedical Informatics in EuropeINBIOMEDvision
 

Tendances (16)

projekat
projekatprojekat
projekat
 
Chemsem news fall 2013 flyer 3
Chemsem news fall 2013 flyer 3Chemsem news fall 2013 flyer 3
Chemsem news fall 2013 flyer 3
 
Heather Heine CV
Heather Heine CVHeather Heine CV
Heather Heine CV
 
Ojp
OjpOjp
Ojp
 
cvofdrayubqureshi-RESEARCH 2
cvofdrayubqureshi-RESEARCH 2cvofdrayubqureshi-RESEARCH 2
cvofdrayubqureshi-RESEARCH 2
 
Foresight in medicine: research induced society changes in the next decade
Foresight in medicine: research induced society changes in the next decadeForesight in medicine: research induced society changes in the next decade
Foresight in medicine: research induced society changes in the next decade
 
ciclo autonomico-short paper - Witfor 2016 paper_42
ciclo autonomico-short paper - Witfor 2016 paper_42ciclo autonomico-short paper - Witfor 2016 paper_42
ciclo autonomico-short paper - Witfor 2016 paper_42
 
Georges Dagher
Georges DagherGeorges Dagher
Georges Dagher
 
AUTOMATED SYSTEM FOR PLANT DISEASE DIAGNOSIS BY USING IMAGE PROCESSING
AUTOMATED SYSTEM FOR PLANT DISEASE DIAGNOSIS BY USING IMAGE PROCESSINGAUTOMATED SYSTEM FOR PLANT DISEASE DIAGNOSIS BY USING IMAGE PROCESSING
AUTOMATED SYSTEM FOR PLANT DISEASE DIAGNOSIS BY USING IMAGE PROCESSING
 
Journal of Neurology | Open Access Journal
Journal of Neurology | Open Access JournalJournal of Neurology | Open Access Journal
Journal of Neurology | Open Access Journal
 
190228 pitch student group 3 microresonator platform to detect cancer (smb me...
190228 pitch student group 3 microresonator platform to detect cancer (smb me...190228 pitch student group 3 microresonator platform to detect cancer (smb me...
190228 pitch student group 3 microresonator platform to detect cancer (smb me...
 
Asb
AsbAsb
Asb
 
Lab'InSight Toxicological Risk Assessment UCL - LTAP 24.10.2013
Lab'InSight Toxicological Risk Assessment UCL - LTAP 24.10.2013Lab'InSight Toxicological Risk Assessment UCL - LTAP 24.10.2013
Lab'InSight Toxicological Risk Assessment UCL - LTAP 24.10.2013
 
Mass spectroscopy
Mass spectroscopyMass spectroscopy
Mass spectroscopy
 
INBIOMEDvision IV Symposium Biomedical Informatics in Europe
INBIOMEDvision  IV Symposium Biomedical Informatics in EuropeINBIOMEDvision  IV Symposium Biomedical Informatics in Europe
INBIOMEDvision IV Symposium Biomedical Informatics in Europe
 
Open Targets talk at the BSPR 2019 meeting
Open Targets talk at the BSPR 2019 meetingOpen Targets talk at the BSPR 2019 meeting
Open Targets talk at the BSPR 2019 meeting
 

Similaire à Mansfield CV 2016 LinkedIN

FDA STAMP Conference on CNS Shunts Agenda January 1999
FDA STAMP Conference on CNS Shunts Agenda January 1999FDA STAMP Conference on CNS Shunts Agenda January 1999
FDA STAMP Conference on CNS Shunts Agenda January 1999Stephen Dolle
 
2014 02-24 Oxford Global biomarker congress, Manchester
2014 02-24 Oxford Global biomarker congress, Manchester2014 02-24 Oxford Global biomarker congress, Manchester
2014 02-24 Oxford Global biomarker congress, ManchesterAlain van Gool
 
Resume 2013 sean ekins
Resume 2013 sean ekinsResume 2013 sean ekins
Resume 2013 sean ekinsSean Ekins
 
Presentation for NGO " The Association for the Health of Society"
Presentation for NGO " The Association for the Health of Society"Presentation for NGO " The Association for the Health of Society"
Presentation for NGO " The Association for the Health of Society"Sofia glinyana
 
Guidelines for the management of hospital-adquired pneumonia ERJ 2017.pdf
Guidelines for the management of hospital-adquired pneumonia ERJ 2017.pdfGuidelines for the management of hospital-adquired pneumonia ERJ 2017.pdf
Guidelines for the management of hospital-adquired pneumonia ERJ 2017.pdfDenisBacinschi2
 
JournalofCancerEpidemiologyandTreatment3
JournalofCancerEpidemiologyandTreatment3JournalofCancerEpidemiologyandTreatment3
JournalofCancerEpidemiologyandTreatment3Christian Schmidt
 
Dubina Michael biomedical technologies at Skolkovo
Dubina Michael biomedical technologies at SkolkovoDubina Michael biomedical technologies at Skolkovo
Dubina Michael biomedical technologies at Skolkovoigorod
 
Tofiq journal of medical sciencesمجلة توفيق العدد الثاني 2015
Tofiq journal of medical sciencesمجلة توفيق العدد الثاني 2015Tofiq journal of medical sciencesمجلة توفيق العدد الثاني 2015
Tofiq journal of medical sciencesمجلة توفيق العدد الثاني 2015Taghreed Al-Noor
 
Literature Evaluation You did a great job on your PICOT and .docx
Literature Evaluation You did a great job on your PICOT and .docxLiterature Evaluation You did a great job on your PICOT and .docx
Literature Evaluation You did a great job on your PICOT and .docxmanningchassidy
 
Nano med july 24 25 2017 tbagchi
Nano med july 24 25 2017 tbagchiNano med july 24 25 2017 tbagchi
Nano med july 24 25 2017 tbagchiTista Bagchi
 
Declan Mulkeen - Increasing the impact of MRC research
Declan Mulkeen - Increasing the impact of MRC research  Declan Mulkeen - Increasing the impact of MRC research
Declan Mulkeen - Increasing the impact of MRC research Medical Research Council
 

Similaire à Mansfield CV 2016 LinkedIN (20)

FDA STAMP Conference on CNS Shunts Agenda January 1999
FDA STAMP Conference on CNS Shunts Agenda January 1999FDA STAMP Conference on CNS Shunts Agenda January 1999
FDA STAMP Conference on CNS Shunts Agenda January 1999
 
2014 02-24 Oxford Global biomarker congress, Manchester
2014 02-24 Oxford Global biomarker congress, Manchester2014 02-24 Oxford Global biomarker congress, Manchester
2014 02-24 Oxford Global biomarker congress, Manchester
 
NanoDelivery 2017_TP
NanoDelivery 2017_TPNanoDelivery 2017_TP
NanoDelivery 2017_TP
 
Marcus-Yaffee-Flier
Marcus-Yaffee-FlierMarcus-Yaffee-Flier
Marcus-Yaffee-Flier
 
Resume 2013 sean ekins
Resume 2013 sean ekinsResume 2013 sean ekins
Resume 2013 sean ekins
 
JPP-2015[1]
JPP-2015[1]JPP-2015[1]
JPP-2015[1]
 
invivo30_web
invivo30_webinvivo30_web
invivo30_web
 
Bookshelf nbk263566
Bookshelf nbk263566Bookshelf nbk263566
Bookshelf nbk263566
 
Presentation for NGO " The Association for the Health of Society"
Presentation for NGO " The Association for the Health of Society"Presentation for NGO " The Association for the Health of Society"
Presentation for NGO " The Association for the Health of Society"
 
Guidelines for the management of hospital-adquired pneumonia ERJ 2017.pdf
Guidelines for the management of hospital-adquired pneumonia ERJ 2017.pdfGuidelines for the management of hospital-adquired pneumonia ERJ 2017.pdf
Guidelines for the management of hospital-adquired pneumonia ERJ 2017.pdf
 
JournalofCancerEpidemiologyandTreatment3
JournalofCancerEpidemiologyandTreatment3JournalofCancerEpidemiologyandTreatment3
JournalofCancerEpidemiologyandTreatment3
 
Health, Climate and Innovation
Health, Climate and InnovationHealth, Climate and Innovation
Health, Climate and Innovation
 
Dubina Michael biomedical technologies at Skolkovo
Dubina Michael biomedical technologies at SkolkovoDubina Michael biomedical technologies at Skolkovo
Dubina Michael biomedical technologies at Skolkovo
 
Tofiq journal of medical sciencesمجلة توفيق العدد الثاني 2015
Tofiq journal of medical sciencesمجلة توفيق العدد الثاني 2015Tofiq journal of medical sciencesمجلة توفيق العدد الثاني 2015
Tofiq journal of medical sciencesمجلة توفيق العدد الثاني 2015
 
MicrofluidicsCongressAgenda
MicrofluidicsCongressAgendaMicrofluidicsCongressAgenda
MicrofluidicsCongressAgenda
 
Literature Evaluation You did a great job on your PICOT and .docx
Literature Evaluation You did a great job on your PICOT and .docxLiterature Evaluation You did a great job on your PICOT and .docx
Literature Evaluation You did a great job on your PICOT and .docx
 
Embolism
EmbolismEmbolism
Embolism
 
Nano med july 24 25 2017 tbagchi
Nano med july 24 25 2017 tbagchiNano med july 24 25 2017 tbagchi
Nano med july 24 25 2017 tbagchi
 
Declan Mulkeen - Increasing the impact of MRC research
Declan Mulkeen - Increasing the impact of MRC research  Declan Mulkeen - Increasing the impact of MRC research
Declan Mulkeen - Increasing the impact of MRC research
 
Roadmap on nanomedicine
Roadmap on nanomedicineRoadmap on nanomedicine
Roadmap on nanomedicine
 

Mansfield CV 2016 LinkedIN

  • 1. Page 1 of 2 COLIN MANSFIELD Address: Lyon, France Citizenship: British PROFESSIONAL HISTORY Principal Medical Writer and IP Manager at AB Science, Paris, France. (June 2008 - present) Marie Curie Research Fellow at Institut des Nanotechnologies, ECL, Lyon, France. (Nov 2006 – June 2008) Research Associate at NRC, Institute for Biodiagnostics, Winnipeg, Canada. (2001 - 2006) PROFESSIONAL SKILLS AND EXPERIENCE Principal Medical Writer for a fully integrated pharmaceutical company that develops targeted therapies in the fields of oncology, immune-mediated diseases and neurological disorders. This entails the drafting, review and editing of clinical study documentation, regulatory submission documentation, and medical communications. More specifically:  Articles for peer-review journals; submission planning; conference abstracts, slide-sets and posters; scientific promotional, webpage and educational materials; press releases.  Marketing authorization (eCTD module 2) and orphan drug designation applications, response to health authorities and affiliate questions, regulatory annual reports (FDA and EMA), clinical study reports according to ICH, Investigator Brochure, scientific rationale, study protocols, informed consent forms, SOPs.  Participant at meetings for EMA centralized marketing authorization application; pre-submission through to Scientific Advisory Group appeal hearings.  Responsible for recruitment of new medical writers and regulatory affairs staff. Intellectual Property Manager primarily entailing drafting and prosecution of pharmaceutical method-of-use patents, intellectual property strategic planning, management of current patents and patent applications, identification of inventions and filing of new patents. Scientific Editor of a book published by Springer Press as part of their Methods in Molecular Biology Series on the topic of microfluidic diagnostics. Lead Scientist on several projects, including clinical and preclinical studies requiring the collection, analysis and reporting of data in the fields of nanobiotechnology and biomedical infrared spectroscopy. Adaptability, self-reliance and teamwork are evident in the breadth of medical/scientific communication tasks undertaken and the variety of senior and junior staff collaborations.
  • 2. Page 2 of 2 ACADEMIC BACKGROUND Optical Research Centre University of Southampton, UK Ph.D. in Biomedical Physics (1994 - 2000) Biomedical Physics Group University of Exeter, UK M.Sc. Medical Physics (1993 - 1994) Royal Holloway University of London, UK B.Sc. Physics with Astrophysics 2:1 (Hons) (1990 - 1993) ACHIEVEMENTS AND FELLOWSHIPS Authored over 25 articles in peer-reviewed journals including eight as first author and three book chapters. Medical writing contributions and critical review acknowledged in many others articles. Book editor: Microfluidic Diagnostics - Methods and Protocols. Series: Methods in Molecular Biology, Volume 949, 2013. Over 100K chapters downloaded to date. Personal project. PCT international patent 10 May 2005 (IPSO 1589-1): CD Mansfield and RA Shaw, National Research Council Canada, “Microfluidic Preconditioning of (Bio)Fluids for Reagent free Infrared Clinical Analysis and Diagnostics”. Research funding from the Marie Curie Intra-European Fellowship, “Lab-on-a-chip based analyzers for point- of-care monitoring of cancer therapy”, 2006: awarded € 161,000. Research funding from the Manitoba Medical Service Foundation, “Point-of-care measurements for chronic kidney disease based upon infrared spectroscopy”, 2005: awarded $ 22,000 CDN. Ph.D. studentship from the Southampton University, UK, 1994: awarded course fees and living allowance. Studentship from Engineering and the Physical Sciences Research Council, “Medical physics MSc programme” at Exeter University, UK, 1993: awarded course fees and living allowance.